校正：瑞博西尼的生物活化途径阐释与代谢物谱分析的质谱方法及代谢
Correction: and metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling.
作者信息
Alsubi Thamer A, Attwa Mohamed W, Bakheit Ahmed H, Darwish Hany W, Abuelizz Hatem A, Kadi Adnan A
机构信息
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P. O. Box 2457 Riyadh 11451 Saudi Arabia
Students' University Hospital, Mansoura University Mansoura 35516 Egypt.
出版信息
RSC Adv. 2020 Jun 23;10(40):23930. doi: 10.1039/d0ra90070b. eCollection 2020 Jun 19.
Abstract
[This corrects the article DOI: 10.1039/D0RA01624A.].
摘要
[本文更正了文章的数字对象标识符：10.1039/D0RA01624A。]
相似文献
1
Correction: and metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling.校正：瑞博西尼的生物活化途径阐释与代谢物谱分析的质谱方法及代谢
RSC Adv. 2020 Jun 23;10(40):23930. doi: 10.1039/d0ra90070b. eCollection 2020 Jun 19.
2
and metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling.瑞博西尼的代谢：一种用于阐明生物活化途径和代谢物谱分析的质谱方法。
RSC Adv. 2020 Jun 12;10(38):22668-22683. doi: 10.1039/d0ra01624a. eCollection 2020 Jun 10.
3
Time of flight mass spectrometry based in vitro and in vivo metabolite profiling of ribociclib and their toxicity prediction.基于飞行时间质谱的体外和体内瑞博西利代谢组学及其毒性预测。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jun 15;1147:122142. doi: 10.1016/j.jchromb.2020.122142. Epub 2020 May 4.
4
Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.更正：强效选择性细胞周期蛋白依赖性激酶4和6抑制剂瑞博西尼（LEE011）在临床前癌症模型中是一种多功能联合用药伙伴。
Oncotarget. 2020 Apr 7;11(14):1289. doi: 10.18632/oncotarget.27407.
5
Strategies for metabolite profiling based on liquid chromatography.基于液相色谱的代谢物谱分析策略。
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 15;1044-1045:103-111. doi: 10.1016/j.jchromb.2017.01.011. Epub 2017 Jan 9.
6
Erratum: Publisher Correction to Volume 1 (2016).勘误：《第1卷（2016年）》的出版商更正。
EJNMMI Radiopharm Chem. 2018 Nov 26;3:13. doi: 10.1186/s41181-018-0049-9. eCollection 2018 Dec.
7
Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology.勘误：《食品科学与生物技术》多篇文章的出版商更正。
Food Sci Biotechnol. 2018 Jun 12;27(4):1245. doi: 10.1007/s10068-018-0398-x. eCollection 2018 Aug.
8
An investigation of the bioactivation potential and metabolism profile of Zebrafish versus human.斑马鱼与人类的生物活化潜力及代谢谱研究。
J Biomol Screen. 2012 Aug;17(7):974-86. doi: 10.1177/1087057112447305. Epub 2012 May 29.
9
Erratum: Publisher Correction: articles initially published in wrong volume.勘误：出版商更正：文章最初发表于错误卷期。
Cell Death Discov. 2019 Jul 10;5:116. doi: 10.1038/s41420-019-0186-2. eCollection 2019.
10
Correction.更正。
Int J Dev Disabil. 2022 Jan 30;67(6):458-459. doi: 10.1080/20473869.2022.2030952. eCollection 2021.
引用本文的文献
1
Acute Hepatitis in a Patient Treated With Ribociclib for Metastatic Breast Carcinoma.
J Med Cases. 2025 Sep 17;16(9):372-380. doi: 10.14740/jmc5163. eCollection 2025 Sep.
Zotero 插件